APP/PS1 mice given PAW showed reduced p-tau deposition in the hippocampus compared to APP/PS1 mice without PAW, and such deposition is considered the beginning site of AD pathology, by comparison of APP/PS1 mice without PAW (Fig. 4). This evidence concerns the gene PSEN1 and Alzheimer disease.